Showing results (111-120 of 925) with videos related to
Sort By:
Pageof 93
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1989
Functional heterogeneity of Leu 19"bright"+ and Leu 19"dim"+ lymphokine-activated killer cellsT M Ellis, R I FisherCurrent Opinion in Oncology|August 9, 2006
The emerging concept of antigen-driven lymphomas: epidemiology and treatment implicationsSusan G Fisher, Richard I FisherCurrent Opinion in Oncology|October 1, 1991
Chemotherapy and combined modality treatment in Hodgkin's diseaseE R Gaynor, R I FisherCancer Research|March 1, 1981
Requirements for successful immunotherapy and chemoimmunotherapy of a murine model of ovarian cancerC P Vanhaelen, R I FisherPersonality & Social Psychology Bulletin|November 11, 2018
Personal Ties and Prejudice: A Meta-Analysis of Romantic Attachment and Ambivalent SexismMolly I Fisher, Matthew D HammondCanadian Medical Association Journal|August 12, 1978
The staging and treatment of epithelial ovarian cancerR C Young, R I FisherSeminars in Oncology|October 1, 1991
Clinical trials of alpha-interferon in the treatment of non-Hodgkin's lymphomaE R Gaynor, R I FisherOncology (Williston Park, N.Y.)|December 1, 1995
Chemotherapy of intermediate-grade non-Hodgkin's lymphoma: is "more" or "less" better?E R Gaynor, R I FisherExpert Review of Anticancer Therapy|January 30, 2004
Iodine-131 tositumomab (Bexxar): radioimmunoconjugate therapy for indolent and transformed B-cell non-Hodgkin's lymphomaJonathan W Friedberg, Richard I FisherDisease-A-Month : DM|September 1, 1989
Recent advances in the management of non-Hodgkin's lymphomasE R Gaynor, R I FisherPageof 93